SPARC and neoplasm: Furthermore, we observed tumor-specific upregulation of LASP1, NUAK1, SPARC, and THBS2 in an independent cohort of 24 oral SCC patients not contained in Oncomine (Figure 5F; Rhodes et al., 2007).